Brand Name
Zegalogue
Generic Name
Dasiglucagon
View Brand Information FDA approval date: January 01, 2023
Classification: Antihypoglycemic Agent
Form: Injection
What is Zegalogue (Dasiglucagon)?
ZEGALOGUE ® is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ZEGALOGUE is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment